Literature DB >> 2683762

Abuse of drugs used to enhance athletic performance.

J C Wagner1.   

Abstract

The ergogenic potential of drugs used by athletes to enhance performance is reviewed, and areas of involvement for pharmacists interested in the problem of drug abuse in athletics are described. Athletes use drugs for therapeutic and recreational purposes, as supposed ergogenic aids, and to mask the presence of other drugs during testing. Because many athletes train for competition and not for health, they may view the risk-to-benefit ratio of ergogenic drugs as favorable and may begin using them at an early age. Alcohol is the drug most commonly used by student athletes. Although alcohol has no ergogenic benefit, it is viewed as a caloric source and an anxiolytic. Amphetamines do not prevent exhaustion but may mask fatigue, which can have dangerous consequences. Anabolic steroids appear to increase strength but frequently cause adverse reactions, primarily involving the hepatic and endocrine systems. Beta-blocking agents have been shown to reduce anxiety, hand tremor, and heart rate in precision sports like archery, but susceptible persons may experience serious adverse effects. Caffeine improves the efficiency of fuel use and reduces fatigue; its use has been banned by several athletic organizations. Neither cocaine nor marijuana causes any increase in strength. Secretion of human growth hormone may be stimulated by a variety of agents, but evidence that any subsequent increases in size and weight occur is lacking. Other substances tried by athletes include vitamins and minerals, naloxone, albuterol, and human recombinant erythropoietin. Opportunities in sports pharmacy exists in the areas of information retrieval and interpretation, drug testing, legislation to reclassify drugs, education, and research.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2683762

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  9 in total

Review 1.  Enhancement of athletic performance with drugs. An overview.

Authors:  J C Wagner
Journal:  Sports Med       Date:  1991-10       Impact factor: 11.136

Review 2.  Drugs and sport. Research findings and limitations.

Authors:  P M Clarkson; H S Thompson
Journal:  Sports Med       Date:  1997-12       Impact factor: 11.136

Review 3.  Cannabis in sport: anti-doping perspective.

Authors:  Marilyn A Huestis; Irene Mazzoni; Olivier Rabin
Journal:  Sports Med       Date:  2011-11-01       Impact factor: 11.136

Review 4.  Broadening horizons: the role of ferroptosis in cancer.

Authors:  Xin Chen; Rui Kang; Guido Kroemer; Daolin Tang
Journal:  Nat Rev Clin Oncol       Date:  2021-01-29       Impact factor: 66.675

5.  Effects of anti-cocaine vaccine and viral gene transfer of cocaine hydrolase in mice on cocaine toxicity including motor strength and liver damage.

Authors:  Yang Gao; Liyi Geng; Frank Orson; Berma Kinsey; Thomas R Kosten; Xiaoyun Shen; Stephen Brimijoin
Journal:  Chem Biol Interact       Date:  2012-08-23       Impact factor: 5.192

6.  Supplement consumption in body builder athletes.

Authors:  Jahangir Karimian; Parivash Shekarchizadeh Esfahani
Journal:  J Res Med Sci       Date:  2011-10       Impact factor: 1.852

7.  Amphetamine use and its associated factors in body builders: a study from Tehran, Iran.

Authors:  Hooman Angoorani; Hooman Narenjiha; Behnoosh Tayyebi; Akhgar Ghassabian; Gelareh Ahmadi; Shervin Assari
Journal:  Arch Med Sci       Date:  2012-05-09       Impact factor: 3.318

Review 8.  The clinical relevance of necroinflammation-highlighting the importance of acute kidney injury and the adrenal glands.

Authors:  Wulf Tonnus; Florian Gembardt; Markus Latk; Simon Parmentier; Christian Hugo; Stefan R Bornstein; Andreas Linkermann
Journal:  Cell Death Differ       Date:  2018-09-17       Impact factor: 15.828

Review 9.  Cell death in pancreatic cancer: from pathogenesis to therapy.

Authors:  Xin Chen; Herbert J Zeh; Rui Kang; Guido Kroemer; Daolin Tang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-07-30       Impact factor: 46.802

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.